AMD3100
Showing 1 - 25 of 81
Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)
Active, not recruiting
- Relapsed Adult ALL
- Relapsed Adult AML
-
Changchun, Jilin, ChinaFirst Hospital of Jilin University
Nov 19, 2023
Healthy Trial run by the NHLBI (AMD 3100 (Mozobil plerixafor), Granulocyte colony-stimulating factor (G-CSF))
Completed
- Healthy
- AMD 3100 (Mozobil plerixafor)
- Granulocyte colony-stimulating factor (G-CSF)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 21, 2021
Multiple Myeloma Trial in Stanford (MGTA-145, Plerixafor)
Completed
- Multiple Myeloma
-
Stanford, CaliforniaStanford University
Aug 17, 2022
Autologous Haematopoietic Stem Cell Transplant Trial in China (plerixafor + G-CSF)
Recruiting
- Autologous Haematopoietic Stem Cell Transplant
- plerixafor + G-CSF
-
China, ChinaInvestigational Sites
May 4, 2022
Infertility of Uterine Origin Trial in San Francisco, Basking Ridge, Philadelphia (AMD3100, Normal saline, dilation and
Terminated
- Infertility of Uterine Origin
- AMD3100
- +2 more
-
San Francisco, California
- +2 more
May 18, 2021
Healthy Volunteers Trial run by the NHLBI (AMD3100)
Completed
- Healthy Volunteers
- AMD3100
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 5, 2020
Fanconi Anemia Trial in Cincinnati (AMD3100, AmCell CliniMACs)
Completed
- Fanconi Anemia
- AMD3100
- AmCell CliniMACs
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 28, 2020
Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia Trial in Stanford
Recruiting
- Allogeneic Hematopoietic Cell Transplantation (HCT)
- +5 more
- Purified regulatory T-cells (Treg) plus CD34+ HSPC
- +7 more
-
Stanford, CaliforniaStanford University
Oct 28, 2021
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Multiple Myeloma Trial in United States (Plerixafor, bortezomib, Dexamethasone)
Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)
Completed
- Stem Cell Transplantation
- Leukemia
- Plerixafor
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 22, 2020
Prostate Adenocarcinoma Trial in Washington (Entinostat, Enzalutamide)
Terminated
- Prostate Adenocarcinoma
-
Washington, District of ColumbiaGeorge Washington University - Medical Faculty Associates
Jul 26, 2021
Fanconi Anemia Trial in Barcelona, Madrid (procedure, biological, other, drug)
Unknown status
- Fanconi Anemia
- IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs)
- +5 more
-
Barcelona, Spain
- +1 more
Nov 23, 2020
HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Plasma Cell Myeloma Trial in Los Angeles
Withdrawn
- HLA-A*0201 Positive Cells Present
- +3 more
- 18F-FHBG
- +10 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Jul 22, 2020
EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary
Completed
- Pancreatic Cancer
- Whipples Surgery
-
Cambridge, England, United KingdomAddenbrooke's Hospital
Jul 15, 2019
Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients
Active, not recruiting
- Multiple Myeloma
-
Torino, ItalyA.O.U. Città della Salute e della Scienza di Torino
Aug 17, 2021
Healthy Trial run by the NHLBI (AMD3100 (Mozobil plerixafor))
Completed
- Healthy
- AMD3100 (Mozobil plerixafor)
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Feb 5, 2018
Adult Ependymoblastoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma Trial in Stanford (radiation, drug, other)
Completed
- Adult Ependymoblastoma
- +8 more
- radiation therapy
- +4 more
-
Stanford, CaliforniaStanford University, School of Medicine
Sep 27, 2018
High Grade Glioma: Glioblastoma (GBM), High Grade Glioma: Gliosarcoma, Anaplastic Astrocytoma (AA) Trial in Boston (Plerixafor,
Terminated
- High Grade Glioma: Glioblastoma (GBM)
- +4 more
- Plerixafor
- +2 more
-
Boston, Massachusetts
- +1 more
Nov 15, 2017
Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)
Completed
- Relapsed/Refractory AML
- +5 more
- Plerixafor Dose Escalation
-
Phoenix, Arizona
- +8 more
Sep 5, 2018
Acute Myeloid Leukemia, Acute Lymphoid Leukemia Trial in Mexico City (Busulfan, Cyclophosphamide, CXCR4 Antagonist)
Unknown status
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- Busulfan
- +3 more
-
Mexico City, Distrito Federal, MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020
Malignant Lymphoma, Stem Cell Type Trial in Halifax (Plerixafor (Mozobil), Plerixafor + G-CSF)
Completed
- Malignant Lymphoma, Stem Cell Type
- Plerixafor (Mozobil)
- Plerixafor + G-CSF
-
Halifax, Nova Scotia, CanadaCapital Health District Authority
Jul 31, 2017
Hematologic Tumors Trial in St. Louis (AMD3100, Leukopheresis, Stem cell transplant)
Completed
- Hematologic Neoplasms
- AMD3100
- +2 more
-
St. Louis, MissouriWashington University School of Medicine
Apr 6, 2017